Boston Scientific Corporation Stock

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 16:00:03 2024-05-31 EDT 5-day change 1st Jan Change
75.61 USD +0.81% Intraday chart for Boston Scientific Corporation -0.03% +30.79%
Sales 2024 * 16B 21.8B Sales 2025 * 17.59B 23.97B Capitalization 111B 151B
Net income 2024 * 2.2B 3B Net income 2025 * 2.73B 3.72B EV / Sales 2024 * 7.35 x
Net Debt 2024 * 6.42B 8.75B Net Debt 2025 * 3.62B 4.94B EV / Sales 2025 * 6.52 x
P/E ratio 2024 *
51.4 x
P/E ratio 2025 *
41.7 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.65%
More Fundamentals * Assessed data
Dynamic Chart
Boston Scientific Insider Sold Shares Worth $4,791,447, According to a Recent SEC Filing MT
Transcript : Boston Scientific Corporation Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-29-2024 08:00 AM
Argus Adjusts Price Target on Boston Scientific to $95 From $80 MT
Boston Scientific Insider Sold Shares Worth $2,504,239, According to a Recent SEC Filing MT
Medtronic beats quarterly profit estimates on medical devices strength RE
Citigroup Adjusts Price Target on Boston Scientific to $87 From $85, Keeps Buy Rating MT
CL King Adjusts Price Target on Boston Scientific to $90 From $82 MT
Boston Scientific Corporation Announces Positive Six-Month Results from the Ongoing Pivotal Modular ATP Clinical Trial of the mCRM System CI
Mizuho Adjusts Price Target on Boston Scientific to $90 From $85, Keeps Buy Rating MT
Transcript : Boston Scientific Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
Boston Scientific Insider Sold Shares Worth $958,717, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $286,874, According to a Recent SEC Filing MT
Boston Scientific Corporation Appoints Cheryl Pegus to its Board of Directors CI
Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing MT
More news
1 day+0.81%
1 week-0.03%
Current month+0.05%
1 month+4.71%
3 months+12.63%
6 months+34.68%
Current year+30.79%
More quotes
1 week
74.43
Extreme 74.43
75.82
1 month
71.82
Extreme 71.82
76.25
Current year
57.11
Extreme 57.11
76.25
1 year
48.35
Extreme 48.35
76.25
3 years
34.98
Extreme 34.98
76.25
5 years
24.10
Extreme 24.1
76.25
10 years
11.10
Extreme 11.1
76.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 11-10-16
Director of Finance/CFO 58 96-11-30
Chief Tech/Sci/R&D Officer - 09-08-31
Members of the board TitleAgeSince
Director/Board Member 71 16-07-12
Director/Board Member 61 21-06-22
Director/Board Member 69 15-03-31
More insiders
Date Price Change Volume
24-05-31 75.57 +0.76% 8,825,296
24-05-30 75 +0.03% 5,150,739
24-05-29 74.98 -0.25% 6,809,504
24-05-28 75.17 -0.61% 4,252,437

Delayed Quote Nyse, May 31, 2024 at 04:00 pm

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
75.57 USD
Average target price
82.06 USD
Spread / Average Target
+8.59%
Consensus